Ajanta Pharma Ltd.

Financial

	Ajanta Pharma	Fortis Healthcare	Sanofi India
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	77.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	55.0 .	n/a	n/a
Domestic Sales Growth - YoY	15.6 %	n/a	0.6 %
R&D as a % of Total Sales	5.0 %	n/a	0.0
Financials
5 yr Average ROE	19.25 %	2.33 %	43.25 %
5yr average Equity Multiplier	1.34	1.73	3.33
5yr Average Asset Turnover Ratio	0.75	0.44	0.57
5yr Avg Net Profit Margin	19.31 %	2.18 %	22.99 %
Price to Book	8.52	4.58	19.37
P/E	37.26	63.01	32.61
5yr Avg Cash Conversion Cycle	19.66 Days	-133.71 Days	11.11 Days
Inventory Days	74.91 Days	6.17 Days	48.47 Days
Days Receivable	99.85 Days	31.7 Days	13.83 Days
Days Payable	219.9 Days	220.67 Days	55.71 Days
5yr Average Interest Coverage Ratio	165.94	3.83	1007.93
5yr Avg ROCE	24.04 %	4.56 %	29.56 %
5yr Avg Operating Profit Margin	29.77 %	14.05 %	28.62 %
5 yr average Debt to Equity	0.01	0.19	0.0
5yr CAGR Net Profit	8.73 %	n/a	41.96 %
5yr Average Return on Assets	14.36 %	1.32 %	13.01 %
Shareholdings
Promoter Holding	66.21 %	31.17 %	60.4 %
Share Pledged by Promoters	12.26 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-4.13 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	5.23 %	14.26 %	1.86 %

Business

	Ajanta Pharma	Fortis Healthcare	Sanofi India
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Out-Patient Services 0 In-Patient Services 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceutical 0 Out-Patient Services 13.51 In-Patient Services 85.57 Pharmaceuticals 0 Others 0.92	Product Wise Break-Up Pharmaceutical 0 Out-Patient Services 0 In-Patient Services 0 Pharmaceutical 100.0
Segment Break-Up	Segment Break-Up Diagnostics 0 Healthcare 0 Others 100	Segment Break-Up Healthcare 80.78 Diagnostic Services 19.22	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Orthopedics 0 Renal 0 Neuro & Spine 0 Gastro 0 Oncology 0 Pulmonology 0 Gynecology 0 Cardiac 0 RESPIRATORY 0 DERMA 0 ANTI-INFECTIVES 0 GASTRO INTESTINAL 0 NEURO/CNS 0 PAIN/ANALGES 0 CARDIAC 0 ANTI DIABETIC 0 VMN 0 Others 100	Therapeutic Area Wise Break-Up - Domestic Oncology 14.2 CARDIAC 0 Gynecology 3.7 NEURO/CNS 0 ANTI DIABETIC 0 ANTI-INFECTIVES 0 Renal 7.4 GASTRO INTESTINAL 0 DERMA 0 VMN 0 Pulmonology 3.1 Central Nervous System (CNS) 8.7 Cardiac Science 17.6 Gastro Intestinal 5.1 Orthopaedics 8.5 RESPIRATORY 0 PAIN/ANALGES 0 Others 31.7	Therapeutic Area Wise Break-Up - Domestic Oncology 0 Cardiac Science 17.42 Gynecology 0 Central Nervous System (CNS) 6.86 Anti - Diabetes 38.81 Anti-Infective 5.72 Renal 0 Gastro Intestinal 10.56 DERMA 0 VMN 0 Pulmonology 0 Neuro & Spine 0 Cardiac 0 Gastro 0 Orthopedics 0 Respiratory Systems 13.48 Pain Management 7.15
Location Wise Break-Up	Location Wise Break-Up India 30.93 Asia Pacific 26.66 USA 24.76 Africa 16.51 Rest of the World 0 South India 0 East India 0 West India 0 North India 0 Singapore 0 Others 1.14	Location Wise Break-Up North India 34.0 Singapore 0 USA 0 East India 14.0 West India 21.0 Rest of the World 3.0 Asia Pacific 0 South India 28.0 Africa 0 India 0	Location Wise Break-Up North India 0 Singapore 17.88 USA 0 East India 0 West India 0 Rest of the World 0 Asia Pacific 0 South India 0 Africa 0 India 81.47 Others 0.65
Asset Break-Up	Asset Break-Up India 99.23 USA 0.44 Asia Pacific 0.23 Africa 0.09 Others 0.01	Asset Break-Up Asia Pacific 0 Africa 0 USA 0 India 98.91 Others 1.09	-

Ajanta Pharma Ltd.

SIGN UP FOR FREE